The Pharmaceuticals and Medical Devices Agency (PMDA; Tokyo, Japan) has granted gastrointestinal medical device maker Given Imaging (NASDAQ:GIVN; Yoqneam, Israel) clearance for the company's PillCam SB 3 capsule endoscopy system. The technology in this third-generation system enables detection and monitoring of small bowel diseases, such as Crohn's disease.
Related: Given Imaging's next-gen PillCam receives FDA approval
Related: Microrobots slide, crawl, and swarm into new applications
Each component of the PillCam SB 3 system, including the capsule, recorder, sensor belt, and software, works together to improve image quality, tissue coverage, and efficiency. Adaptive frame rate technology also allows the capsule to automatically increase the rate at which images are taken when it senses it is moving more quickly through the digestive tract. Improvements in the new system's RAPID for PillCam software enable video compilation that is 40% more efficient than its previous-generation PillCam SB 2.
The company expects to begin recognizing sales of PillCam SB 3 in Japan in 2014.
Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn
Subscribe now to BioOptics World magazine; it's free!